Projected Cardiovascular Benefit of GLP-1 Receptor Agonist Therapy in Obese Patients Without Diabetes Undergoing Complex Percutaneous Coronary Intervention. // The American Journal of Cardiology. – URL: https://www.sciencedirect.com/science/article/pii/S0002914926006879?dgcid=rss_sd_all
Projected Cardiovascular Benefit of GLP-1 Receptor Agonist Therapy in Obese Patients Without Diabetes Undergoing Complex Percutaneous Coronary Intervention. The American Journal of Cardiology. https://www.sciencedirect.com/science/article/pii/S0002914926006879?dgcid=rss_sd_all
“Projected Cardiovascular Benefit of GLP-1 Receptor Agonist Therapy in Obese Patients Without Diabetes Undergoing Complex Percutaneous Coronary Intervention.” The American Journal of Cardiology.
@article{article101517,
title = {Projected Cardiovascular Benefit of GLP-1 Receptor Agonist Therapy in Obese Patients Without Diabetes Undergoing Complex Percutaneous Coronary Intervention},
journal = {The American Journal of Cardiology},
url = {https://www.sciencedirect.com/science/article/pii/S0002914926006879?dgcid=rss_sd_all}
}